摘要
合成了一系列含噻唑烷二酮-3-乙酸结构的新型查尔酮衍生物,并对化合物进行了抗菌活性测定.结果显示,一些化合物对4种多重耐药菌显示出较强的抗菌活性,其中化合物8g,8i,8l和8m在抗耐甲氧西林金黄色葡萄球菌的最小抑制浓度(MIC)达到4μg/mL,与对照药诺氟沙星(norfloxacin)相当.另外,在64μg/mL浓度下,所有化合物对大肠杆菌1356均无明显抑制活性.
A series of novel chalcone derivatives bearing the 2,4-thiazolidinedione-3-acetic acid moieties(8a~8p) were synthesized,and evaluated for their anti-bacterial activity.The results demonstrated that some compounds presented good antimicrobial activities against four multidrug-resistant clinical isolates,among which compounds 8g,8i,8l and 8m with minimum inhibitory concentration(MIC) value of 4 μg/mL showed as active as the standard drug,norfloxacin,against methi-cillin-resistant S.aureus.None of the compounds exhibited obvious activity against the Gram-negative bacteria E.coli 1356 at 64 μg/mL.
出处
《有机化学》
SCIE
CAS
CSCD
北大核心
2012年第1期183-188,共6页
Chinese Journal of Organic Chemistry
基金
国家自然科学基金(No.20962021)资助项目~~
关键词
查尔酮
噻唑烷二酮-3-乙酸
抗菌活性
chalcone
2
4-thiazolidinedione-3-acetic acid
anti-bacterial activity